Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer C Rödel, P Martus, T Papadoupolos, L Füzesi, M Klimpfinger, ... Journal of clinical oncology 23 (34), 8688-8696, 2005 | 1464 | 2005 |
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy BM Ghadimi, M Grade, MJ Difilippantonio, S Varma, R Simon, ... Journal of clinical oncology 23 (9), 1826-1838, 2005 | 439 | 2005 |
Cytogenetics of papillary renal cell tumors G Kovacs, L Fuzesi, A Emanuel, HF Kung Genes, Chromosomes and Cancer 3 (4), 249-255, 1991 | 412 | 1991 |
Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway JH Lee, D Schütte, G Wulf, L Füzesi, HJ Radzun, S Schweyer, W Engel, ... Human molecular genetics 15 (2), 201-211, 2006 | 338 | 2006 |
Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours C Langer, B Gunawan, P Schüler, W Huber, L Füzesi, H Becker Journal of British Surgery 90 (3), 332-339, 2003 | 288 | 2003 |
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array JM Boer, WK Huber, H Sültmann, F Wilmer, A Von Heydebreck, S Haas, ... Genome research 11 (11), 1861-1870, 2001 | 247 | 2001 |
Prognosis factors in incisional hernia surgery: 25 years of experience C Langer, A Schaper, T Liersch, B Kulle, M Flosman, L Füzesi, H Becker Hernia 9, 16-21, 2005 | 221 | 2005 |
Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical … C Langer, T Liersch, M Süss, A Siemer, P Markus, B Ghadimi, L Füzesi, ... International journal of colorectal disease 18, 222-229, 2003 | 194 | 2003 |
Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization F Haller, B Kulle, S Schwager, B Gunawan, A von Heydebreck, ... Analytical biochemistry 335 (1), 1-9, 2004 | 172 | 2004 |
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors L Matyakhina, TA Bei, SR McWhinney, B Pasini, S Cameron, B Gunawan, ... The Journal of Clinical Endocrinology & Metabolism 92 (8), 2938-2943, 2007 | 170 | 2007 |
Parvovirus B19 detected in Rosai–Dorfman disease in nodal and extranodal manifestations Y Mehraein, M Wagner, K Remberger, L Füzesi, P Middel, S Kaptur, ... Journal of clinical pathology 59 (12), 1320-1326, 2006 | 156 | 2006 |
Her-2/neu Gene Amplification and Protein Expression in Primary Male Breast Cancer C Rudlowski, N Friedrichs, A Faridi, L Füzesi, R Moll, G Bastert, W Rath, ... Breast cancer research and treatment 84, 215-223, 2004 | 145 | 2004 |
Collecting duct carcinoma: cytogenetic characterization L Füzesi, M Cober, CH Mittermayer Histopathology 21 (2), 155-160, 1992 | 144 | 1992 |
Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants A Agaimy, B Märkl, J Kitz, PH Wünsch, H Arnholdt, L Füzesi, A Hartmann, ... Virchows Archiv 456, 411-422, 2010 | 135 | 2010 |
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: Gain of 5q31–qter predicts a distinct clinical phenotype with favorable prognosis B Gunawan, W Huber, M Holtrup, A von Heydebreck, T Efferth, A Poustka, ... Cancer research 61 (21), 7731-7738, 2001 | 132 | 2001 |
Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations F Haller, S Detken, HJ Schulten, N Happel, B Gunawan, J Kuhlgatz, ... Annals of surgical oncology 14, 526-532, 2007 | 131 | 2007 |
Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors B Gunawan, A von Heydebreck, T Fritsch, W Huber, RH Ringert, G Jakse, ... Cancer research 63 (19), 6200-6205, 2003 | 128 | 2003 |
An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications B Gunawan, A von Heydebreck, B Sander, HJ Schulten, F Haller, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 122 | 2007 |
Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors B Gunawan, F Bergmann, J Höer, C Langer, V Schumpelick, H Becker, ... Human pathology 33 (3), 316-321, 2002 | 115 | 2002 |
Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors F Haller, B Gunawan, A Von Heydebreck, S Schwager, HJ Schulten, ... Clinical cancer research 11 (18), 6589-6597, 2005 | 111 | 2005 |